Patent · US Active

Synthetic composition and method for treating irritable bowel syndrome

US11026959B2 · kind B2 · utility

4Cited by

1References

20Claims

0Family size

Assignee

GLYCOM A/S · DK

Inventors

Thierry Hennet · Otelfingen, CH
Bruce McConnell · La Tour-de-Peilz, CH
Emma Elison · Malmö, SE
Louise Kristine Vigsnæs · Middelfart, DK

Key dates

Filing date	Feb 14, 2018
Grant date	Jun 8, 2021
Priority date	—
Expiry date	Feb 14, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The application relates to a method for treating a patient with irritable bowel syndrome (IBS), the method comprising administering to the patient a mixture comprising 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.